liposomal glutathione health benefits clinical evidence Supplement Liposomal glutathione as a promising

Ci thin tn hiu t bo: Gia tng tn hiu t bo gip bn tp trung hn v gia tng s kt ni c bp v no b gip bn vn ng hiu qu hn, t pht trin c bp tt hn

10.1016/j.marpolbul.2015.12.041 79 Lacoue-LabartheT.ReveillacE.OberhnsliF.TeyssiJ

The combination of BSO+L-PAM achieved synergistic cytotoxicity (combination index number (CIN) 0.7) and induced 24 logs of cell kill in all nine MM cell lines including the eight lines established at progressive disease (PD) after therapy (U266, OPM-2, NCI H929, KMS-12-PE, EJM, TX-MM-030h, MM.1S and MOLP-2), 25 which include lines with cytogenetic profiles associated with a poor prognosis (Figure 1b)

Reconstitution Best Practices: When reconstituting AOD-9604 , allow both the peptide vial and bacteriostatic water to reach room temperature to minimize temperature shock

Future Research Directions Clinical Trial Priorities Several research areas should be prioritized to advance understanding of BPC-157 and TB-500 therapeutic applications